This marked advertorial is for informational and advertising purposes only and does not constitute medical advice
303.1 Understanding the experience of people living with amyotrophic lateral sclerosis: a qualitative study and conceptual model informed by patients, caregivers, and clinicians William Nowell 1 , Nadine McGale 2 , Oren Levy 1 , Sarah Wilding 2 , Phoebe Heinrich 2 , Nick Patel 1 , Jinsy Andrews 3 , Diana Rofail 1 1 Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, 2 Modus Outcomes, Cambridge, Massachusetts, USA, 3 Department of Neurology, Colombia University, New York, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :303.1 Aims This qualitative study aimed to (1) explore the experience of living with amyotrophic lateral sclerosis (ALS) through interviews with patients, caregivers, and clinicians, and (2) develop a conceptual model for this rare, progressive disease
Menopause brings more than just hot flashesit can come with surprising symptoms that affect your hair, teeth, skin, nails, and even brain function
We identified evidence supporting broad effects of semaglutide, implicating processes related to body weight regulation, glycemic control, lipid metabolism and inflammatory pathways
Continuous ofatumumab treatment up to 7 years shows a consistent safety profile and delays disability progression in people with relapsing multiple sclerosis
